© 2021 MJH Life Sciences and Neurology Live. All rights reserved.
© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Key insight into treating ATTR Amyloidosis, including the use of new therapeutic options to provide a practical perspective on how recent data may apply to your clinical practice.
March 12th 2021
Panelists offer an overarching view into hereditary ATTR amyloidosis and differentiate the condition from wild-type ATTR amyloidosis.
Analysis on the prevalence of hereditary ATTR amyloidosis.
March 19th 2021
A discussion on understanding the disparities of race and gender in hereditary ATTR amyloidosis.
Signs and symptoms to help determine a diagnosis of hereditary ATTR.
March 26th 2021
Understanding the diagnostic process in making a ATTR amyloidosis diagnosis.
Panelists suggest how to differentiate between diabetic neuropathy and ATTR amyloidosis.
April 2nd 2021
Diagnostic criteria commonly used to ensure an accurate diagnosis of hereditary ATTR amyloidosis is dissected.
Expert panelists provide recommendations for gene panel testing with genetic counseling for evaluation of patients with hereditary ATTR amyloidosis.
April 9th 2021
Various types of biopsies to diagnosis hereditary ATTR amyloidosis are discussed.
The use of mass spectrometry is the gold standard in amyloid proteins.